BACKGROUND: Past series have identified completion pneumonectomy (CP) as a high-risk operation. We evaluated factors affecting outcomes of CP with a selective approach to offering this operation. METHODS: We analyzed a prospective institutional database and abstracted information on patients undergoing pneumonectomy. Patients undergoing CP were compared with those undergoing primary pneumonectomy (PP). RESULTS: Between January 2000 and February 2011, 211 patients underwent pneumonectomy, of which 35 (17%) were CPs. Ten of 35 (29%) CPs were for benign disease and 25 of 35 (71%) for cancer. Major perioperative morbidity was seen in 21 of 35 (60%) with 4 (11%) perioperative deaths. In univariate analysis, postoperative bronchopleural fistula (p = 0.05) and benign diagnosis (p = 0.07) tended to be associated with perioperative mortality. All 10 patients undergoing CP for benign disease developed a major complication compared with 11 of 25 (44%) with malignancy, p = 0.002. A bronchopleural fistula (4 of 35, 11%) was more likely to occur in patients undergoing CP shortly after the primary operation (interval between lobectomy and CP; 0.28 vs 4.5 years; p = 0.018) with a trend toward a benign indication for operation (p = 0.07). Median survival after CP for benign and malignant indications was 24.3 months and 36.5 months, respectively. Comparing CP patients to those undergoing PP (n = 176), CP patients were more likely to undergo an operation for benign disease (10 of 35, 29% vs 14 of 176, 8%, p = 0.001). Perioperative mortality for PP was 10 of 176 (5.7%), and was statistically similar to CP (11%). CONCLUSIONS: Despite a selective approach, CP remains a morbid operation, particularly for benign indications. Rigorous preoperative optimization, ruling out contraindications to operation and attention to technical detail, are recommended.
BACKGROUND: Past series have identified completion pneumonectomy (CP) as a high-risk operation. We evaluated factors affecting outcomes of CP with a selective approach to offering this operation. METHODS: We analyzed a prospective institutional database and abstracted information on patients undergoing pneumonectomy. Patients undergoing CP were compared with those undergoing primary pneumonectomy (PP). RESULTS: Between January 2000 and February 2011, 211 patients underwent pneumonectomy, of which 35 (17%) were CPs. Ten of 35 (29%) CPs were for benign disease and 25 of 35 (71%) for cancer. Major perioperative morbidity was seen in 21 of 35 (60%) with 4 (11%) perioperative deaths. In univariate analysis, postoperative bronchopleural fistula (p = 0.05) and benign diagnosis (p = 0.07) tended to be associated with perioperative mortality. All 10 patients undergoing CP for benign disease developed a major complication compared with 11 of 25 (44%) with malignancy, p = 0.002. A bronchopleural fistula (4 of 35, 11%) was more likely to occur in patients undergoing CP shortly after the primary operation (interval between lobectomy and CP; 0.28 vs 4.5 years; p = 0.018) with a trend toward a benign indication for operation (p = 0.07). Median survival after CP for benign and malignant indications was 24.3 months and 36.5 months, respectively. Comparing CP patients to those undergoing PP (n = 176), CP patients were more likely to undergo an operation for benign disease (10 of 35, 29% vs 14 of 176, 8%, p = 0.001). Perioperative mortality for PP was 10 of 176 (5.7%), and was statistically similar to CP (11%). CONCLUSIONS: Despite a selective approach, CP remains a morbid operation, particularly for benign indications. Rigorous preoperative optimization, ruling out contraindications to operation and attention to technical detail, are recommended.
Authors: M Sirmali; S Karasu; S Gezer; H Türüt; G Findik; G Oz; K Aydogdu; S Kaya; A I Tastepe; N Karaoglanoglu Journal: Thorac Cardiovasc Surg Date: 2008-06 Impact factor: 1.827
Authors: T Fujimoto; G Zaboura; S Fechner; L Hillejan; T Schröder; A Marra; T Krbek; M Hinterthaner; D Greschuchna; G Stamatis Journal: J Thorac Cardiovasc Surg Date: 2001-03 Impact factor: 5.209
Authors: Giuseppe Cardillo; Domenico Galetta; Paul van Schil; Andrea Zuin; Pierluigi Filosso; Robert J Cerfolio; Anna Rita Forcione; Francesco Carleo Journal: Eur J Cardiothorac Surg Date: 2012-03-06 Impact factor: 4.191
Authors: Rachel M Owen; Seth D Force; Allan Pickens; Kamal A Mansour; Daniel L Miller; Felix G Fernandez Journal: Eur J Cardiothorac Surg Date: 2012-05-18 Impact factor: 4.191
Authors: A Terzi; A Lonardoni; G Falezza; P Scanagatta; A Santo; G Furlan; F Calabrò Journal: Eur J Cardiothorac Surg Date: 2002-07 Impact factor: 4.191
Authors: Jacob Klapper; Sameer Hirji; Matthew G Hartwig; Thomas A D'Amico; David H Harpole; Mark W Onaitis; Mark F Berry Journal: J Am Coll Surg Date: 2014-04-08 Impact factor: 6.113
Authors: Marco Mammana; Giuseppe Marulli; Andrea Zuin; Egle Perissinotto; Giovanni Maria Comacchio; Elisa De Franceschi; Federico Rea Journal: Surg Today Date: 2019-09-06 Impact factor: 2.549
Authors: Seyer Safi; Axel Benner; Janos Walloschek; Maria Renner; Jan op den Winkel; Thomas Muley; Konstantina Storz; Hendrik Dienemann; Hans Hoffmann; Thomas Schneider Journal: PLoS One Date: 2015-04-09 Impact factor: 3.240
Authors: Abby White; Suden Kucukak; Daniel N Lee; Raphael Bueno; Michael Jaklitsch; Steven Mentzer; David Sugarbaker; Jon Wee; Scott J Swanson Journal: J Thorac Dis Date: 2020-03 Impact factor: 3.005